-
公开(公告)号:US11660337B2
公开(公告)日:2023-05-30
申请号:US17502116
申请日:2021-10-15
Inventor: Fengyan Li , Xiuwei Shu , Bo Wang , Yiping Wang , Wenyou Luo , Shenglei Chen , Yanxia Liu
IPC: A61K39/29 , A61K39/23 , A61K39/175 , A61K39/00
CPC classification number: A61K39/29 , A61K39/175 , A61K39/23 , A61K2039/552 , C12N2710/10334 , C12N2750/14034 , C12N2760/18434
Abstract: The present invention discloses a combination of vaccine strains for treating, preventing, relieving or controlling Canine Distemper, Canine Parvovirus Enteritis and Canine Infectious Hepatitis, comprising: Canine Distemper virus vaccine strain with the microorganism deposition accession number CGMCC No. 19397, Canine Parvovirus vaccine strain with the microorganism deposition accession number CGMCC No. 19398 and Canine Infectious Hepatitis virus vaccine strain with the microorganism deposition accession number CGMCC No. 19396. The three vaccine strains of the combination of vaccine strains are low in toxicity and good in immunogenicity. The present invention further discloses a live vaccine composition using the above-mentioned combination of vaccine strains as immunogen. The vaccine composition is safe and effective.
-
公开(公告)号:US20220118083A1
公开(公告)日:2022-04-21
申请号:US17502116
申请日:2021-10-15
Inventor: Fengyan Li , Xiuwei Shu , Bo Wang , Yiping Wang , Wenyou Luo , Shenglei Chen , Yanxia Liu
Abstract: The present invention discloses a combination of vaccine strains for treating, preventing, relieving or controlling Canine Distemper, Canine Parvovirus Enteritis and Canine Infectious Hepatitis, comprising: Canine Distemper virus vaccine strain with the microorganism deposition accession number CGMCC No. 19397, Canine Parvovirus vaccine strain with the microorganism deposition accession number CGMCC No. 19398 and Canine Infectious Hepatitis virus vaccine strain with the microorganism deposition accession number CGMCC No. 19396. The three vaccine strains of the combination of vaccine strains are low in toxicity and good in immunogenicity. The present invention further discloses a live vaccine composition using the above-mentioned combination of vaccine strains as immunogen. The vaccine composition is safe and effective.
-